Armstrong Dematic: Driving a New Era of Logistics Excellence

Armstrong Dematic: Driving a New Era of Logistics Excellence

Vinit Majgaonkar, Chairman, Armstrong Dematic

Today, pharmaceutical organizations require seamless integration of compliance, traceability, temperature control & security in their supply chains. In this endeavor, they must modernize the intra-logistics at both the manufacturing unit and the distribution center, which are areas long neglected in favor of ramping up production. For decades, the industry focused on aligning manufacturing capabilities with global good manufacturing practices, however, the disruptions triggered by COVID-19 exposed deep vulnerabilities in distribution networks. The backlog in supply chain innovation has accelerated investments in digital tracking, cold chain infrastructure, and e-pharmacy integrations while complying with evolving regulatory mandates. End-to-end traceability has also emerged as a significant challenge, particularly for high-value drugs requiring stringent temperature controls. Simultaneously, the rapid ascent of quick commerce is reshaping expectations, as consumers and healthcare providers demand near-instant access to critical medications.

Balancing speed, security, and compliance remains a delicate act, with logistics providers increasingly expected to offer solutions that integrate automation with rigorous oversight. Addressing these complexities requires specialized automation solutions that ensure regulatory adherence while optimizing speed and efficiency, and Armstrong Dematic offers just that. An intralogistics and warehouse automation solutions provider, the company specializes in the design and implementation of advanced solutions that optimize storage, sorting, and order fulfillment processes across various industries. From pharmaceutical behemoths handling high volume, variety, and value of SKUs to mid-sized organizations forming consortiums of 10 to 15 companies to establish shared distribution channels, its solutions offer three core benefits.

Visibility, Velocity, & Space Optimization

The company’s advanced automation systems ensure real-time product tracking at every stage of the supply chain. Beyond traditional QR codes and barcodes, Armstrong Dematic integrates AI-driven monitoring, capturing images or short video clips when products are transferred between locations. This provides verifiable proof of movement, particularly critical in sensitive environments such as pharmaceutical supply chains. The company's solutions adhere to stringent industry standards, including 21 CFR Part 11 and GMP compliance, ensuring regulatory alignment. Pharmaceutical organizations can confidently monitor their supply chains, reducing the risks associated with counterfeit drugs and ensuring product authenticity from production to delivery.

Furthermore, Armstrong Dematic is one of the leaders in intralogistics automation where ‘velocity’ plays a vital role. “We have successfully increased operational speeds by four to five times within the same space while reducing manpower requirements to just one-fourth of previous levels”, says Vinit Majgaonkar, Chairman, Armstrong Dematic.

While manual loading remains prevalent in India, the company also offers automated truck loading systems to further optimize efficiency.

When it comes to storage capacity, traditional warehouses, with their 10 to 12-meter storage height, limit the scalability of pharmaceutical distribution centers. Armstrong Dematic’s automated storage systems extend up to 40 meters, reducing the overall footprint required for storage by 75 percent. In addition, its high-density storage solutions maximize efficiency in temperature-controlled warehouses, doubling storage density compared to standard automated systems and achieving up to four to eight times the capacity of manual storage. This conserves warehouse space and reduces energy costs associated with climate-controlled storage.

With the growing emphasis on reducing carbon footprints and optimizing energy consumption, Armstrong Dematic is introducing green logistics solutions

Beyond Storage & Retrieval

The company offers a comprehensive end-to-end order fulfillment solution, far beyond the conventional automation of storage and retrieval. While many pharmaceutical organizations have adopted automated storage and retrieval systems (ASRS) in isolated pockets, Armstrong Dematic integrates every stage of the fulfillment process, from the end of the production line to final dispatch, much like e-Commerce logistics. The process begins at the packaging stage, where primary packs such as capsule strips or bottles are placed into secondary cartons, labeled, and recorded for traceability. These cartons are then transported to its proprietary robotic palletizing system, which meticulously arranges and maps their position on a pallet for complete SKU traceability. The company’s autonomous mobile robots (AMRs) transport these pallets either directly to dispatch for cross-docking or to ASRS for optimized storage. Its systems ensure strict adherence to FIFO (First-In-First-Out) protocols, preventing expired inventory from being overlooked. As pioneers in ASRS technology, the company, through its partnership with Dematic, the global inventor of ASRS, offers unmatched storage density and visibility.

Beyond ASRS, Armstrong Dematic’s patented software solutions drive intelligent order fulfillment, enabling precise sequencing for optimized dispatch. Instead of merely moving full pallets, the system dynamically picks and compiles mixed orders based on route efficiency, ensuring that trucks are loaded in a logical LIFO sequence for streamlined last-mile delivery. The company’s orchestration software seamlessly integrates AMRs, robotic palletizers, high-speed sorters, and other automated systems, ensuring synchronized operations. At the core of this orchestration is Dematic IQ, globally recognized as the industry’s most advanced order fulfillment software.

Compliant & Sustainable Solutions

Armstrong Dematic’s approach to automation encompasses both hardware and software, ensuring a seamless, compliant, and data-driven solution for its clients. As an end-to-end consultant, the company begins by analyzing customer data and forecasts with its in-house data science team to develop solutions that incorporate compliance standards from the conceptualization stage itself. The Systems Engineering Department ensures adherence to global regulatory frameworks, including cGMP, FDA, EU GDP guidelines, 21 CFR Part 11, and ISO certifications, while also maintaining international safety standards in automation and robotics. On the software front, the company provides a robust regulatory trail with stringent data security, high visibility, and advanced traceability features.

It also understands that automation in pharmaceutical logistics is not just about efficiency, it is also about sustainability. With the growing emphasis on reducing carbon footprints and optimizing energy consumption, Armstrong Dematic is introducing green logistics solutions. Its automated warehouses incorporate energy-efficient technologies such as smart lighting, solar-powered operations, and AI-driven climate control to minimize waste and emissions. By integrating sustainability with automation, the company helps pharmaceutical firms align with global environmental goals while enhancing their bottom line.

The future of pharmaceutical logistics will likely see even greater integration of robotics. The differentiation between leading brands is no longer solely based on product quality but on the efficiency and reliability of their supply chains, an area where Armstrong Dematic plays a pivotal role. The shift toward automation has been further fueled by the consolidation of warehouses following the introduction of GST, with companies moving from fragmented, state-level facilities to centralized hubs serving multiple regions. This shift has created economies of scale, making automation investments more viable and necessary. “While five years ago, typical investments in warehouse automation ranged around ?10 crore, the market has now escalated to ?25-50 crore, with projections indicating a rise to ?50-100 crore in the next three years”, says Vinit. Armstrong Dematic is one of the few companies in India equipped to handle such large-scale, complex projects, leveraging its global expertise in automation, where project sizes often exceed ?500-1,000 crores. With a quarter century experience in the Indian market and access to world-class technology, it can deliver solutions tailored to the unique needs of Indian businesses, setting a new benchmark in supply chain efficiency.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.